A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects

AIM: Dolutegravir (DTG; S/GSK1349572) is under clinical development as a once daily, unboosted integrase inhibitor for the treatment of HIV infection. The effect of DTG on glomerular filtration rate (GFR), effective renal plasma flow (ERPF), and creatinine clearance (CL(cr)) was evaluated in 34 heal...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Koteff, Justin, Borland, Julie, Chen, Shuguang, Song, Ivy, Peppercorn, Amanda, Koshiba, Takaaki, Cannon, Courtney, Muster, Heather, Piscitelli, Stephen C
Format: Artigo
Sprog:Inglês
Udgivet: Blackwell Science Inc 2013
Fag:
Clinical Trials
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612717/
https://ncbi.nlm.nih.gov/pubmed/22905856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2125.2012.04440.x
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker